Key result
Targeted cardioprotective therapies reduce apoptosis and infarct size in preclinical acute myocardial ischemia.
Answers are grounded in this paper and cite their sources.
In addition to necrosis, apoptosis makes a significant contribution to cell death following acute myocardial ischemia; apoptosis is particularly enhanced during reperfusion. Several studies are beginning to indicate that the cell death by apoptosis may be preventable. A boost in the research in this direction has been provided by noninvasive means of detection of apoptosis, such as that achieved by technetium-99m labeled Annexin-A5 scintigraphy. Various levels within the apoptotic cascade are being investigated as therapeutic targets. Caspase inhibitors, mitochondrial stabilizers, and Na+-H+ exchanger inhibitors reduce cell death by apoptosis and infarct size. Although most of the evidence at present is limited to the laboratory animals, this approach seems to hold a promise for the future.
No takes yet. Share an insight, caveat, or question.
Garg et al. (2003) conducted a review in Acute myocardial ischemia. Caspase inhibitors, mitochondrial stabilizers, and Na+-H+ exchanger inhibitors was evaluated on Cell death by apoptosis and infarct size. Caspase inhibitors, mitochondrial stabilizers, and Na+-H+ exchanger inhibitors reduce apoptotic cell death and infarct size in acutely ischemic myocardium in preclinical models.
Synapse has enriched 10 related papers. Consider them for comparative context: